{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:18:48Z","timestamp":1784121528144,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,14]]},"DOI":"10.7759\/cureus.105224","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:22:48Z","timestamp":1773498168000},"source":"Crossref","is-referenced-by-count":2,"title":["Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations"],"prefix":"10.7759","author":[{"given":"Corneliu N","family":"Stanciu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2024.2424278","article-title":"Kratom consumption - the tales of three patients","volume":"58","author":"Gnanasegaram SA","year":"2026","unstructured":"Gnanasegaram SA, Sexton L, Stanciu CN. Kratom consumption - the tales of three patients. J Psychoactive Drugs. 2026, 58:41-4. 10.1080\/02791072.2024.2424278","journal-title":"J Psychoactive Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2023.2289456","article-title":"Prevalence, characteristics, and reasons for kratom use among psychiatrically ill inpatients who use substances","volume":"20","author":"Stanciu CN","year":"2024","unstructured":"Stanciu CN, Ahmed S, Sarfraz Z, et al.. Prevalence, characteristics, and reasons for kratom use among psychiatrically ill inpatients who use substances. J Dual Diagn. 2024, 20:87-97. 10.1080\/15504263.2023.2289456","journal-title":"J Dual Diagn"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2022.2111685","article-title":"Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature","volume":"48","author":"Stanciu C","year":"2022","unstructured":"Stanciu C, Ahmed S, Gnanasegaram S, Gibson S, Penders T, Grundmann O, McCurdy C. Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature. Am J Drug Alcohol Abuse. 2022, 48:509-28. 10.1080\/00952990.2022.2111685","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112701","article-title":"De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing","volume":"272","author":"Hill K","year":"2025","unstructured":"Hill K, Boyer EW, Grundmann O, Smith KE. De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. Drug Alcohol Depend. 2025, 272:112701. 10.1016\/j.drugalcdep.2025.112701","journal-title":"Drug Alcohol Depend"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2025.2522162","article-title":"A descriptive assessment of products containing the opioid receptor stimulator mitragynine pseudoindoxyl","volume":"60","author":"White CM","year":"2025","unstructured":"White CM, Belcourt J, Sedensky A. A descriptive assessment of products containing the opioid receptor stimulator mitragynine pseudoindoxyl. Subst Use Misuse. 2025, 60:1950-4. 10.1080\/10826084.2025.2522162","journal-title":"Subst Use Misuse"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00075","article-title":"Metabolism of a kratom alkaloid metabolite in human plasma increases its opioid potency and efficacy","volume":"3","author":"Kamble SH","year":"2020","unstructured":"Kamble SH, Le\u00f3n F, King TI, et al.. Metabolism of a kratom alkaloid metabolite in human plasma increases its opioid potency and efficacy. ACS Pharmacol Transl Sci. 2020, 3:1063-8. 10.1021\/acsptsci.0c00075","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"V\u00e1radi A","year":"2016","unstructured":"V\u00e1radi A, Marrone GF, Palmer TC, et al.. Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2. J Med Chem. 2016, 59:8381-97. 10.1021\/acs.jmedchem.6b00748","journal-title":"J Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2021.35.S1.05475","article-title":"Assessment of contribution of 7-hydroxymitragynine and mitragynine pseudoindoxyl to the MU-opioid activity of mitragynine","volume":"35","author":"Crowley M","year":"2021","unstructured":"Crowley M, Obeng S, Patel A, et al.. Assessment of contribution of 7-hydroxymitragynine and mitragynine pseudoindoxyl to the MU-opioid activity of mitragynine. FASEB J. 2021, 35:10.","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.02.032","article-title":"Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone","volume":"15","author":"Wentland MP","year":"2005","unstructured":"Wentland MP, Lu Q, Lou R, Bu Y, Knapp BI, Bidlack JM. Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone. Bioorg Med Chem Lett. 2005, 15:2107-10. 10.1016\/j.bmcl.2005.02.032","journal-title":"Bioorg Med Chem Lett"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.001","article-title":"Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument","volume":"105","author":"Tompkins DA","year":"2009","unstructured":"Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend. 2009, 105:154-9. 10.1016\/j.drugalcdep.2009.07.001","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-025-01631-7","article-title":"The impact of diverse kratom products on use patterns, dependence, and toxicity","volume":"27","author":"Vadiei N","year":"2025","unstructured":"Vadiei N, Evoy KE, Grundmann O. The impact of diverse kratom products on use patterns, dependence, and toxicity. Curr Psychiatry Rep. 2025, 27:584-92. 10.1007\/s11920-025-01631-7","journal-title":"Curr Psychiatry Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1562133","article-title":"Kratom withdrawal: a systematic review with case series","volume":"51","author":"Stanciu CN","year":"2019","unstructured":"Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T. Kratom withdrawal: a systematic review with case series. J Psychoactive Drugs. 2019, 51:12-8. 10.1080\/02791072.2018.1562133","journal-title":"J Psychoactive Drugs"},{"key":"ref13","article-title":"Pharmacotherapy for management of 'kratom use disorder': a systematic literature review with survey of experts","volume":"120","author":"Stanciu C","year":"2021","unstructured":"Stanciu C, Ahmed S, Hybki B, Penders T, Galbis-Reig D. Pharmacotherapy for management of 'kratom use disorder': a systematic literature review with survey of experts. WMJ. 2021, 120:54-61.","journal-title":"WMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467977-severe-early-onset-withdrawal-following-intentional-use-of-mitragynine-pseudoindoxyl-a-case-report-and-emerging-clinical-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:22:49Z","timestamp":1773498169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467977-severe-early-onset-withdrawal-following-intentional-use-of-mitragynine-pseudoindoxyl-a-case-report-and-emerging-clinical-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.105224","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,14]]}}}